Skip to main content
. 2023 Sep 27;11:e16132. doi: 10.7717/peerj.16132

Figure 3. Effects of allicin at 60 days of follow-up on:

Figure 3

Body weight (A), systolic blood pressure (B), fasting blood glucose (C), and oral glucose tolerance test (OGTT) (D). Lipid profile in plasma: triglycerides (E), total cholesterol (F), LDL cholesterol (G), and HDL cholesterol (H). C, control; MS, metabolic syndrome; MS+A, metabolic syndrome + allicin. Data are expressed as mean ± SEM and analysed by one-way ANOVA. Statistical significance was established as *p < 0.05 vs. C; #p < 0.05 vs. MS.